April McClain Delaney
Suspicious Timing Detected
5 flagsApril McClain Delaney bought $1,001 - $15,000 in $LH on 2026-02-11, 1 day before the Veterans Community Care Scheduling Improvement Act (HR3482) was introduced, a bill that could affect healthcare scheduling services.
April McClain Delaney bought $1,001 - $15,000 in $LH on 2026-02-04, 7 days before the Rural Health Care Facilities Revitalization Act (HR7514) was introduced, a bill that could impact rural healthcare infrastructure.
April McClain Delaney bought $1,001 - $15,000 in $LH on 2026-02-11, 21 days before HR7787, a bill to strengthen the mental health workforce, was introduced.
April McClain Delaney bought $1,001 - $15,000 in $LH on 2026-02-11, 26 days before HR7868, a bill to amend the Public Health Service Act regarding organ donation, was introduced.
April McClain Delaney bought $1,001 - $15,000 in $LH on 2026-02-11, 71 days before The Lewin Group, a subsidiary of Optum (UnitedHealth Group), secured an $11.3M Department of Health and Human Services contract.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Date |
|---|---|---|---|---|
| BUY | $CHRW | C.H. Robinson Worldwide, Inc. - Common Stock (CHRW) [ST] | $15K-$50K | Feb 13, 2026 |
| BUY | $CLH | Clean Harbors, Inc. Common Stock (CLH) [ST] | $15K-$50K | Feb 23, 2026 |
| BUY | $ROL | Rollins, Inc. Common Stock (ROL) [ST] | $15K-$50K | Feb 13, 2026 |
| BUY | $BRO | Brown & Brown, Inc. Common Stock (BRO) [ST] | $1K-$15K | Feb 6, 2026 |
| BUY | $CHRW | C.H. Robinson Worldwide, Inc. - Common Stock (CHRW) [ST] | $1K-$15K | Feb 6, 2026 |
| BUY | $CHRW | C.H. Robinson Worldwide, Inc. - Common Stock (CHRW) [ST] | $1K-$15K | Feb 5, 2026 |
| BUY | $CHRW | C.H. Robinson Worldwide, Inc. - Common Stock (CHRW) [ST] | $1K-$15K | Feb 9, 2026 |
| BUY | $EME | EMCOR Group, Inc. Common Stock (EME) [ST] | $1K-$15K | Feb 27, 2026 |
| BUY | $EME | EMCOR Group, Inc. Common Stock (EME) [ST] | $1K-$15K | Feb 4, 2026 |
| BUY | $LH | Labcorp Holdings Inc. Common Stock (LH) [ST] | $1K-$15K | Feb 11, 2026 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Medical Nutrition Therapy Act of 2026
The Medical Nutrition Therapy Act of 2026 structurally expands Medicare Part B to cover nutrition counseling for obesity, cancer, HIV/AIDS, and eating disorders — a direct benefit expansion for MA insurers Humana, UnitedHealth, Centene, and CVS Health, which can integrate these services to manage chronic disease costs. The bill is early-stage (referred to Senate Finance, 2 co-sponsors), but real market data shows the affected tickers have experienced 19-70% 30-day gains, reflecting broader sector momentum.
Small Business Dependent Care FSA Opportunity Act
HR7922 (Small Business Dependent Care FSA Opportunity Act) introduces a targeted tax credit for small employers' dependent care FSA startup costs, creating a structural tailwind for FSA administrators like PAYX, ADP, and WEX. The bill is early-stage (referred to Ways & Means) with a net-zero federal revenue impact given the credit structure, limiting near-term urgency but providing a clear medium-term adoption catalyst.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
HR8129, a bill to create a permanent full risk ACO program in traditional Medicare, is at early legislative stage with low momentum (1 cosponsor, 2 committees). Despite this, the four largest Medicare Advantage insurers ($UNH, $HUM, $CNC, $CVS) have already rallied sharply over 30 days — $CNC +62.34%, $HUM +38.49%, $UNH +35.85%, $CVS +16.05% — indicating investors are pricing in the structural shift to value-based care regardless of this specific bill's passage timeline.
Veterans Community Care Scheduling Improvement Act
HR3482 is a procedural authorization bill requiring the VA to build an online scheduling system for community care appointments. It mandates an IT system change but includes no explicit funding, and it does not directly increase patient volume or reimbursement rates. The market impact on healthcare stocks ($DGX, $LH, $HCA, $UHS, $AMN) is negligible in the near term.
Rural Health Care Facilities Revitalization Act
HR7514 is an early-stage bill with no funding authorized and no path to passage evident — 3 cosponsors, referred to committee on introduction date only. Real market data shows $GEHC down -15.58% over 30 days and $TDOC flat at +0.37%. The market is correctly not pricing in any impact from this bill. No actionable trade signal exists.
Smart Space Act of 2026
HR 7388 (Smart Space Act) directs GSA to hire private-sector CRE experts for federal building PPPs, directly benefiting pure-play real estate services firms $CBRE and $JLL. At the current early legislative stage with zero appropriated funding, the near-term market impact is moderate. $CBRE sits at $142.17, down 4.13% in the past week; $JLL at $318.32, down 5.98% — both are trading well off their 52-week highs, and this legislative catalyst provides a demand signal with limited downside risk.
To amend title VII of the Public Health Service Act to strengthen the mental health workforce, and for other purposes.
HR7787 is an early-stage bill authorizing a mental health provider loan forgiveness program. It has been referred to committee with no companion bill, zero appropriations, and minimal legislative momentum. Market impact is negligible at this stage. Real market data shows AMN Healthcare at $20.65, up 12.6% over 30 days, and Centene at $53.22, up 62.55% over 30 days, driven by other factors unrelated to this procedural bill.
To amend the Public Health Service Act with respect to the Living Organ Donation Reimbursement Program.
HR7868, the 'Expanding Support for Living Donors Act of 2026,' is an early-stage bill authorizing up to $10,000 per donor for qualifying expenses in FY2027. Actual appropriations are required. The market reaction in diagnostic ($LH, $DGX) and device ($MDT, $SYK) stocks is currently driven by broader market trends — all four stocks are down 2-9% over the past 30 days — not by this bill's introduction. The legislative impact on revenue is negligible at this stage.
Expanded Telehealth Access Act
The Expanded Telehealth Access Act (S.3834) is an early-stage Senate bill that permanently adds audiologists, physical therapists, occupational therapists, speech-language pathologists, and assistants to Medicare telehealth eligibility. No funding is authorized. Market data shows mixed conviction: TDOC down 4.87% in the last 7 days to $5.47, while AMWL gained 3.06% to $6.06, indicating no material premium is priced in for this low-probability legislative event.
Improving Access to Care for Rural Veterans Act
S.3033 mandates VA-rural hospital partnerships, creating revenue tailwinds for rural hospital operators ($HCA, $UHS) and healthcare staffing ($AMN) through mandatory co-location, leasing, and telehealth agreements. The bill is out of committee with bipartisan sponsorship but lacks funding authorization — actual impact requires future appropriations. Recent market data shows $AMN up 12.2% in 30 days, while $HCA and $UHS have declined sharply on separate sector pressures.
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.